background image

Crohn's Disease Clinical Trials

Find clinical trials for crohn's disease. Search for crohn's disease clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

for
Crohn's Disease
Location: Kissimmee FL, Iowa City IA, New Orleans LA,
Sponsor: Alimentiv Inc.

Sex: All

Age: 18+

Code: NCT06249555

Recruiting
Active & Responsive

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

for
Crohns Disease, Pregnancy, Inflammatory Bowel Disease
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT06001450

Recruiting
Active & Responsive

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

for
Ulcerative Colitis, Crohn's Disease
Location: Phoenix AZ, Minneapolis MN
Sponsor: Takeda

Sex: All

Age: 2+

Code: NCT05442567

Phase3, Recruiting
Active & Responsive

Treatment of Moderate to Severe Refractory Crohn's Disease

for
Crohns Disease
Location: Sacramento CA, San Francisco CA, Chicago IL,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT06721962

Phase1, Phase2, Recruiting
Active & Responsive

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

for
Crohns Disease
Location: Rochester MN, St Louis MO, Cleveland OH, Hamilton,
Sponsor: Alimentiv Inc.

Sex: All

Age: 18+

Code: NCT06670638

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

for
Perianal Fistula Due to Crohn's Disease
Location: New York NY
Sponsor: Direct Biologics, LLC

Sex: All

Age: 18 - 70+

Code: NCT06918808

Phase2, Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Los Angeles CA, Murrieta CA, Orange CA, Clearwater FL,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase2, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Dothan AL, Phoenix AZ, Sun City AZ, Garden Grove CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Dothan AL, Phoenix AZ, Sun City AZ, Tucson AZ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase3, Recruiting
Active & Responsive

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

for
Inflammatory Bowel Disease (IBD), Crohn's Disease,
Location: New York NY, Chapel Hill NC
Sponsor: Mercy Medical Center

Sex: All

Age: 18+

Code: NCT06750731

Recruiting